Literature DB >> 28405250

The management of venous thromboembolism: A practical tool for the front-line clinician.

Tammy J Bungard1, William Semchuk1.   

Abstract

Entities:  

Year:  2017        PMID： 28405250      PMCID： PMC5384527          DOI： 10.1177/1715163517691062

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  25 in total

1.  Aspirin for preventing the recurrence of venous thromboembolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

2.  Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Bonno van Bellen; Luke Bamber; Francine Correa de Carvalho; Martin Prins; Maria Wang; Anthonie W A Lensing
Journal:  Curr Med Res Opin       Date:  2014-01-22       Impact factor: 2.580

3.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

Review 4.  Pulmonary embolism and deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Henri Bounameaux
Journal:  Lancet       Date:  2012-04-10       Impact factor: 79.321

Review 5.  A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism.

Authors:  C Kearon
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

6.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Patrick Mismetti; Sebastian Schellong; Henry Eriksson; David Baanstra; Janet Schnee; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

7.  Symptoms, location and prognosis of pulmonary embolism.

Authors:  M T García-Sanz; C Pena-Álvarez; P López-Landeiro; A Bermo-Domínguez; T Fontúrbel; F J González-Barcala
Journal:  Rev Port Pneumol       Date:  2014-01-22

Review 8.  Treatment of venous thromboembolism.

Authors:  Philip S Wells; Melissa A Forgie; Marc A Rodger
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

9.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

10.  Apixaban for extended treatment of venous thromboembolism.

Authors:  Giancarlo Agnelli; Harry R Buller; Alexander Cohen; Madelyn Curto; Alexander S Gallus; Margot Johnson; Anthony Porcari; Gary E Raskob; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2012-12-08       Impact factor: 91.245
View more
  1 in total

1.  Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review.

Authors:  Mandana Khodashahi; Zahra Rezaieyazdi; Maryam Sahebari
Journal:  Arch Rheumatol       Date:  2019-12-12       Impact factor: 1.472
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.